Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.4M Hold
759,564
1.43% 20
2026
Q1
$30.4M Buy
759,564
+67,743
+10% +$3.21M 1.74% 17
2025
Q4
$31.6M Buy
691,821
+133,340
+24% +$6.17M 1.83% 13
2025
Q3
$24.7M Buy
558,481
+39,063
+8% +$1.87M 1.69% 17
2025
Q2
$24.9M Sell
519,418
-7,307
-1% -$318K 1.9% 14
2025
Q1
$20.9M Sell
526,725
-6,375
-1% -$268K 1.73% 17
2024
Q4
$24.4M Buy
533,100
+135,675
+34% +$6.08M 1.9% 15
2024
Q3
$18.5M Hold
397,425
1.58% 16
2024
Q2
$17M Buy
+397,425
New +$17.4M 1.46% 17

Other funds holding QGEN

DNCA Finance's QGEN Position: Q2 2026 in Review

DNCA Finance held its Qiagen (QGEN) position steady in Q2 2026 at 759,564 shares worth $29.4M. The position accounts for 1.43% of the portfolio, ranked #20.

DNCA Finance first reported a position in QGEN in Q2 2024 and has held it in 9 quarters since. The position peaked at $31.6M in Q4 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • DNCA Finance held 759,564 shares of Qiagen worth $29.4M as of Q2 2026.
  • DNCA Finance left its Qiagen share count unchanged in Q2 2026.
  • Qiagen made up 1.43% of DNCA Finance's portfolio in Q2 2026, its #20 holding.
  • DNCA Finance first reported a position in Qiagen in Q2 2024 and has held it in 9 quarters since.
  • DNCA Finance's Qiagen position peaked at $31.6M in Q4 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on DNCA Finance's 13F filing for Q2 2026, filed 13 Aug 2026.